Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not sure which part some of you don't understand

This letter refers to one tactical event in an overall strategy to build shareholder value.  Being limited to discuss this one event shouldn't preclude the company from sharing information on other parts of the strategy, such as progress on creating new revenue streams separate from licensing, e.g., mergers, acquisitions, or joint ventures.

Right now, I'd be happy just to hear whether custodial services are being maintained at the office LOL.

Share
New Message
Please login to post a reply